嗜铬细胞瘤及副神经节瘤不同生化表型的CT征象对比研究

赵晓芳, 杨萍, 刘柳, 李庆姝, 李易, 陶奉明, 毛芸

PDF(3177 KB)
PDF(3177 KB)
重庆医科大学学报 ›› 2024, Vol. 49 ›› Issue (02) : 203-209. DOI: 10.13406/j.cnki.cyxb.003433
临床研究 DOI:10.13406/j.cnki.cyxb.003433

嗜铬细胞瘤及副神经节瘤不同生化表型的CT征象对比研究

作者信息 +

Computed tomography signs of pheochromocytomas and paragangliomas with different biochemical phenotypes: a comparative study

Author information +
History +

摘要

目的 分析生化阴性嗜铬细胞瘤及副神经节瘤(pheochromocytomas and paragangliomas,PPGLs)的电子计算机断层扫描(computed tomography,CT)征象是否有别于生化阳性PPGLs,同时了解生化阳性PPGLs不同表型的CT征象是否存在差异。 方法 回顾性分析131例PPGLs患者的术前腹部增强CT图像,包括肿瘤位置、大小、形态、囊变坏死、液-液分层、钙化、向心结节状强化、肿瘤内粗大血管、强化包膜、绝对廓清率及相对廓清率。根据生化水平,将患者分为生化阳性组和阴性组,阳性组进一步分为去甲肾上腺素型、肾上腺素型及多巴胺型。比较各组及各表型间的CT征象差异。 结果 相较于生化阴性组,阳性组PPGLs更大(Z=-2.064,P=0.039)、囊变坏死(χ2 =6.610,P=0.010)及向心结节状强化(χ2 =3.909,P=0.048)的比例更高;相较于去甲肾上腺素型,肾上腺素型PPGLs更大(Z=-2.036,P=0.042)、强化包膜比例更高(χ2 =7.242,P=0.007)。 结论 肿瘤大小、囊变坏死及向心结节状强化的CT征象有助于术前诊断生化阴性PPGLs,肿瘤大小及强化包膜有助于解释去甲肾上腺素型及肾上腺素型PPGLs不同临床表现产生的机制。

Abstract

Objective To investigate whether the computed tomography(CT) signs of biochemically negative paragangliomas and pheochromocytomas (PPGLs) differ from those of biochemically positive PPGLs and whether there are differences in CT signs between different phenotypes of biochemically positive PPGLs. Methods A retrospective analysis was performed for the preoperative abdominal contrast-enhanced CT images of 131 patients with PPGLs,including tumor location,size,shape,cystic change and necrosis,fluid-fluid stratification,calcification,nodular centripetal enhancement,large blood vessels in tumor,enhancing capsule,absolute percentage washout,and relative percentage washout. According to biochemistry,the patients were divided into biochemically positive group and biochemically negative group,and the biochemically positive group was further divided into norepinephrine phenotype group,adrenaline phenotype group,and dopamine phenotype group. CT signs were compared between each group and different phenotypes. Results Compared with the biochemically negative group,the biochemically positive group had significantly larger PPGLs(Z=-2.064,P=0.039) and a significantly higher proportion of patients with cystic change and necrosis(χ2 =6.610,P=0.010) or nodular centripetal enhancement(χ2 =3.909,P=0.048),and compared with the norepinephrine phenotype group,the epinephrine phenotype group had significantly larger PPGLs(Z=-2.036,P=0.042) and a significantly higher proportion of patients with enhancing capsule(χ2 =7.242,P=0.007). Conclusion The CT signs of tumor size,cystic change and necrosis,and nodular centripetal enhancement can help with the diagnosis of biochemically negative PPGLs before surgery,and tumor size and enhancing capsule can help to explain the mechanism of different clinical manifestations of PPGLs with norepinephrine phenotype or epinephrine phenotype.

关键词

嗜铬细胞瘤 / 副神经节瘤 / 甲氧基肾上腺素类物质 / 电子计算机断层扫描 / 诊断

Key words

pheochromocytomas / paragangliomas / metanephrines / computed tomography / diagnosis

中图分类号

R736.6

引用本文

导出引用
赵晓芳 , 杨萍 , 刘柳 , . 嗜铬细胞瘤及副神经节瘤不同生化表型的CT征象对比研究. 重庆医科大学学报. 2024, 49(02): 203-209 https://doi.org/10.13406/j.cnki.cyxb.003433
Zhao Xiaofang, Yang Ping, Liu Liu, et al. Computed tomography signs of pheochromocytomas and paragangliomas with different biochemical phenotypes: a comparative study[J]. Journal of Chongqing Medical University. 2024, 49(02): 203-209 https://doi.org/10.13406/j.cnki.cyxb.003433

参考文献

1
王庭俊,谢良地 .《嗜铬细胞瘤和副神经节瘤诊断治疗专家共识(2020版)》解读[J]. 中华高血压杂志202129(8):708-714.
Wang TJ Xie L. Interpretation of expert consensus on the diagnosis and treatment of pheochromocytoma and paraganglioma(2020 edition)[J]. Chin J Hypertens202129(8):708-714.
2
Kline GA Boyd J Polzin B,et al. Properly collected plasma metanephrines excludes PPGL after false-positive screening tests[J]. J Clin Endocrinol Metab2021106(8):e2900-e2906.
3
赵乃蕊,袁戈恒,张俊清. 488例肾上腺意外瘤住院患者临床特征及诊疗[J]. 重庆医科大学学报202247(6):652-656.
Zhao NR Yuan GH Zhang JQ. Clinical research of 488 inpatients with adrenal incidentaloma[J]. J Chongqing Med Univ202247(6):652-656.
4
Eisenhofer G Prejbisz A Peitzsch M,et al. Biochemical diagnosis of chromaffin cell tumors in patients at high and low risk of disease:plasma versus urinary free or deconjugated O-methylated catecholamine metabolites[J]. Clin Chem201864(11):1646-1656.
5
Kawashima A Sone M Inagaki N,et al. Pheochromocytoma and paraganglioma with negative results for urinary metanephrines show higher risks for metastatic diseases[J]. Endocrine202174(1):155-162.
6
Zhao L Zhang XR Meng X,et al. The clinical characteristics of pheochromocytomas and paragangliomas with negative catecholamines[J]. J Clin Med202211(19):5583.
7
Lenders JW Duh QY Eisenhofer G,et al. Pheochromocytoma and paraganglioma:an endocrine society clinical practice guideline[J]. J Clin Endocrinol Metab201499(6):1915-1942.
8
Li MH Pamporaki C Fliedner SMJ,et al. Metastatic pheochromocytoma and paraganglioma:signs and symptoms related to catecholamine secretion[J]. Discov Oncol202112(1):9.
9
Eisenhofer G Timmers HJ Lenders JW,et al. Age at diagnosis of pheochromocytoma differs according to catecholamine phenotype and tumor location[J]. J Clin Endocrinol Metab201196(2):375-384.
10
Eisenhofer G Deutschbein T Constantinescu G,et al. Plasma metanephrines and prospective prediction of tumor location,size and mutation type in patients with pheochromocytoma and paraganglioma[J]. Clin Chem Lab Med202059(2):353-363.
11
Geroula A Deutschbein T Langton K,et al. Pheochromocytoma and paraganglioma:clinical feature-based disease probability in relation to catecholamine biochemistry and reason for disease suspicion[J]. Eur J Endocrinol2019181(4):409-420.
12
Spiro A Usman A Ajmal A,et al. Asymptomatic and biochemically silent pheochromocytoma with characteristic findings on imaging[J]. Case Rep Endocrinol20202020:8847261.
13
Kumar S Parmar KM Aggarwal D,et al. Simple adrenal cyst masquerading clinically silent giant cystic pheochromocytoma[J]. BMJ Case Rep201912(9):e230730.
14
Galatola R Romeo V Simeoli C,et al. Characterization with hybrid imaging of cystic pheochromocytomas:correlation with pathology[J]. Quant Imaging Med Surg202111(2):862-869.
15
An YY Yang GZ Lin B,et al. Differentiation of lipid-poor adenoma from pheochromocytoma on biphasic contrast-enhanced CT[J]. Abdom Radiol202146(9):4353-4361.
16
Andreoni C Krebs RK Bruna PC,et al. Cystic phaeochromocytoma is a distinctive subgroup with special clinical,imaging and histological features that might mislead the diagnosis[J]. BJU Int2008101(3):345-350.
17
Velasquez G Nath PH Zollikofer C,et al. The “ring sign” of necrotic pheochromocytoma[J]. Radiology1979131(1):69-71.
18
王玲玲,马 茹,昌红,等. 肾上腺嗜铬细胞瘤的临床病理特征分析[J]. 临床肿瘤学杂志202025(3):257-260.
Wang LL Ma R Chang H,et al. Clinicopathological analysis of adrenal pheochromocytoma[J]. Chin Clin Oncol202025(3):257-260.

基金

重庆医科大学未来医学青年创新团队支持计划资助项目(W0096)

评论

PDF(3177 KB)

Accesses

Citation

Detail

段落导航
相关文章

/